14-azacamptothecin: A potent water-soluble topoisomerase I poison

被引:102
作者
Cheng, KJ [1 ]
Rahier, NJ [1 ]
Eisenhauer, BM [1 ]
Gao, R [1 ]
Thomas, SJ [1 ]
Hecht, SM [1 ]
机构
[1] Univ Virginia, Dept Biol & Chem, Charlottesville, VA 22904 USA
关键词
D O I
10.1021/ja0442769
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
On the basis of an analysis of luotonin A and its D-ring deaza analogue as topoisomerase I poisons and topoisomerase I-dependent cytotoxic agents, a novel analogue of the structurally related antitumor antibiotic camptothecin (CPT) was prepared. 14-Azacamptothecin was found to have much greater aqueous solubility than CPT, to inhibit topoisomerase I-mediated DNA relaxation more efficiently than CPT, and to stabilize the covalent binary complex to almost the same extent. 14-Aza CPT was found to be slightly less active than CPT in mediating cytotoxicity toward yeast expressing human topoisomerase I, possibly as a consequence of its greater off-rate from the CPT-topoisomerase I-DNA ternary complex. Copyright © 2005 American Chemical Society.
引用
收藏
页码:838 / 839
页数:2
相关论文
共 23 条
[1]  
BJORNSTI MA, 1989, CANCER RES, V49, P6318
[2]   Synthesis and topoisomerase I inhibitory properties of luotonin A analogues [J].
Cagir, A ;
Eisenhauer, BM ;
Gao, R ;
Thomas, SJ ;
Hecht, SM .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (23) :6287-6299
[3]   Synthesis and biochemical properties of E-ring modified luotonin A derivatives [J].
Cagir, A ;
Jones, SH ;
Eisenhauer, BM ;
Gao, R ;
Hecht, SM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) :2051-2054
[4]   Luotonin A. A naturally occurring human DNA topoisomerase I poison [J].
Cagir, A ;
Jones, SH ;
Gao, R ;
Eisenhauer, BM ;
Hecht, SM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (45) :13628-13629
[5]   Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-Camptothecin hybrids [J].
Fox, BM ;
Xiao, XS ;
Antony, S ;
Kohlhagen, G ;
Pommier, Y ;
Staker, BL ;
Stewart, L ;
Cushman, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (15) :3275-3282
[6]  
Garcia-Carbonero R, 2002, CLIN CANCER RES, V8, P641
[7]  
GOTTLIEB JA, 1972, CANCER CHEMOTH REP 1, V56, P103
[8]   MODIFICATION OF THE HYDROXY LACTONE RING OF CAMPTOTHECIN - INHIBITION OF MAMMALIAN TOPOISOMERASE-I AND BIOLOGICAL-ACTIVITY [J].
HERTZBERG, RP ;
CARANFA, MJ ;
HOLDEN, KG ;
JAKAS, DR ;
GALLAGHER, G ;
MATTERN, MR ;
MONG, SM ;
BARTUS, JO ;
JOHNSON, RK ;
KINGSBURY, WD .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) :715-720
[9]  
HSIANG YH, 1989, CANCER RES, V49, P5077
[10]  
HSIANG YH, 1985, J BIOL CHEM, V260, P4873